NCT05645107 2025-12-16A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaGrifols Therapeutics LLCPhase 3 Recruiting386 enrolled
NCT06520163 2025-12-04Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for LymphomaThe Affiliated People's Hospital of Ningbo UniversityPhase 3 Recruiting99 enrolled